Video: Financing life sciences on both sides of the border

A sneak preview for the final installment of our webinar series, “The future of life sciences in Canada”

The pandemic has been a turning point for investment in life sciences—but what does this mean for investors as well as life sciences companies looking to find opportunity in the industry?

In their latest video, Cheryl Reicin, Chris Bornhorst and Mike Pedlow give a sneak peek on some of the topics from our upcoming life sciences webinar on Thursday, December 10, where they will unpack the current state of financing for life sciences companies, including:

  • a trend for going public in the United States through the use of special purpose acquisition companies;
  • how a number of Canadian companies conduct U.S. initial public offerings without listing in Canada and whether this is a worrisome trend;
  • what advantages the multijurisdictional disclosure system provides to Canadian life sciences companies; and
  • how the COVID-19 pandemic has highlighted the importance and role of life sciences companies now more than ever.

Play the teaser below and register for the webinar on December 10.

To discuss these issues, please contact the author(s).

This publication is a general discussion of certain legal and related developments and should not be relied upon as legal advice. If you require legal advice, we would be pleased to discuss the issues in this publication with you, in the context of your particular circumstances.

For permission to republish this or any other publication, contact Janelle Weed.

© 2021 by Torys LLP.
All rights reserved.


Get in Touch